title: An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again.
authors: European Society for Medical Oncology (ESMO), Lugano, Switzerland; Ludwig Boltzmann Institute for Applied Cancer Research (LBI-ACR VIEnna)-LB Cluster Translational Oncology, Centre for Oncology and Haematology, Kaiser Franz Josef-Spital, Vienna, Austria. Electronic address: christian.dittrich@wienkav.at.
authors: C
authors: C
authors: Dittrich
authors: European Organisation for Research and Treatment of Cancer (EORTC), Brussels; International Regulatory and Intergroup Office, EORTC Headquarters, Brussels, Belgium.
authors: A
authors: A
authors: Negrouk
authors: European Society for Medical Oncology (ESMO), Lugano, Switzerland; Department of Cancer Medicine, Istituto Nazionale Tumori, Milan, Italy.
authors: P G
authors: PG
authors: Casali
mesh_terms: D006801:Humans; D001675:Bioethics; D002986:Clinical Trials as Topic / Q000941:ethics / Q000592:standards; D003163:Competitive Behavior; D032921:Consensus; D005060:Europe; D007258:Informed Consent / Q000592:standards; D018579:Patient Selection; D011050:Policy Making; D012107:Research Design / Q000592:standards; D017410:Practice Guidelines as Topic; D003245:Consensus Statements as Topic